Provided by Tiger Trade Technology Pte. Ltd.

NovaBridge Biosciences

3.25
+0.03501.09%
Volume:182.37K
Turnover:578.73K
Market Cap:374.04M
PE:-10.76
High:3.31
Open:3.30
Low:3.05
Close:3.21
52wk High:6.79
52wk Low:0.5950
Shares:115.27M
Float Shares:48.23M
Volume Ratio:0.85
T/O Rate:0.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3017
EPS(LYR):-0.2738
ROE:-18.46%
ROA:-10.36%
PB:1.44
PE(LYR):-11.85

Loading ...

Top Wall Street Analysts' Latest Ratings: Amazon Downgraded, Roblox Upgraded

Deep News
·
Feb 07

NovaBridge Biosciences Unveils February 2026 Investor Presentation Highlighting Global Hub-and-Spoke Biotech Strategy

TIPRANKS
·
Feb 06

NovaBridge Biosciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Feb 06

NovaBridge resumed with a Buy at H.C. Wainwright

TIPRANKS
·
Feb 06

Novabridge Biosciences : H.c. Wainwright Raises Target Price to $9 From $7

THOMSON REUTERS
·
Feb 06

NovaBridge Biosciences Shares Rise After Chairman Pledges to Buy Shares

Dow Jones
·
Jan 21

NovaBridge announces open market purchases by executive chairman Fu Wei

TIPRANKS
·
Jan 20

Novabridge Announces Open Market Purchases by Executive Chairman, Fu Wei

THOMSON REUTERS
·
Jan 20

NovaBridge Biosciences Executive Chairman Begins Up to $5 Million Open-Market ADS Purchase

TIPRANKS
·
Jan 17

BUZZ-U.S. STOCKS ON THE MOVE-United Airlines Holdings, Energy companies, Tesla

Reuters
·
Jan 07

What's Going On With NovaBridge Stock Tuesday?

Benzinga
·
Jan 07

BUZZ-U.S. STOCKS ON THE MOVE-Shake Shack, Arrowhead Pharmaceuticals, Lockheed Martin

Reuters
·
Jan 06

BUZZ-U.S. STOCKS ON THE MOVE-Alkermes, Ball Corp, NovaBridge

Reuters
·
Jan 06

Novabridge Biosciences Shares Climb 6.9% Premarket After Cancer Drug Shows Promise in Early Trial

THOMSON REUTERS
·
Jan 06

BUZZ-NovaBridge rises as cancer drug shows promise in early trial

Reuters
·
Jan 06

NovaBridge Biosciences Reports Positive Phase 1b Results for Givastomig in Metastatic Gastric Cancer

Reuters
·
Jan 06

Novabridge Presents Positive Givastomig Dose Expansion Data From the Phase 1B Combination Study in Patients With 1L Metastatic Gastric Cancer

THOMSON REUTERS
·
Jan 06

Novabridge Biosciences - Safety Profile of Combination Similar to Earlier Observations; Immune-Related Gastritis Noted

THOMSON REUTERS
·
Jan 06

Novabridge Biosciences - Givastomig Shows 77% Orr at 8 Mg/Kg and 73% at 12 Mg/Kg

THOMSON REUTERS
·
Jan 06

Novabridge Biosciences - Combination Was Well Tolerated; Safety Is Comparable to Current Standard of Care Treatment

THOMSON REUTERS
·
Jan 06